Abstract
Objectives
We seek to summarize the clinicopathologic characteristics and prognostic factors of sarcomatoid renal cell carcinoma (SRCC), an uncommon type of renal cell carcinoma.
Methods and materials
Between 2004 and 2012, 23 patients with SRCC were treated at a large urology center in south central China. We collect patient’s clinicopathologic features from medical records to assess diagnosis, prognostic factors and efficacy of systemic therapy. Clinical data were absent in 3 cases, and 20 patients were enrolled in the final study.
Results
Immunohistochemically, almost all SRCC expressed cytokeratin (91 %), epithelial membrane antigen (87 %) and vimentin (100 %). Sarcomatoid differentiation occurs in various kinds of subtypes of RCC with almost the same probability. The median tumor size was 10.5 cm. The CT findings of these tumors revealed low-density (n = 5; 25 %) or mixed (n = 15; 75 %) masses with necrotic areas and often showed an infiltrative morphology (n = 15; 75 %). All 20 cases demonstrated heterogeneous enhancement, and eleven (55 %) cases demonstrated >50 % necrosis. Six cases complicated with calculus and hydronephrosis. Sixteen (80 %) patients demonstrated invasions of tissues localized in Gerota’s fascia, and 8 (40 %) tumors invaded beyond Gerota’s fascia. Fifteen (75 %) patients demonstrated lymph node metastasis, and sixteen (80 %) patients had distant metastasis. Five patients received systemic therapy, and one patient given high-dose interferon-α had a completely response, and one patient received chemotherapy based on gemcitabine had partial response. The median overall survival of all patients was 5.8 months. Patients without distant metastasis had a median overall survival of 35 months compared with 3 months of those with distant metastasis (P < 0.002). The percentage of the sarcomatoid components did not have an obvious influence to the prognosis (P = 0.197).
Conclusions
Heterogeneity, hugeness, infiltration and necrosis are typical image features of SRCC. The prognosis of SRCC is poor and clinic stage especially the existence of distant disease is the important factor influencing prognosis.
Similar content being viewed by others
References
Bhandari A, Alassi O, Rogers C, MacLennan GT (2010) Squamous cell carcinoma of the renal pelvis. J Urol 183:2023–2024. doi:10.1016/j.juro.2010.02.2370
Cheville JC, Lohse CM, Zincke H, Weaver AL, Leibovich BC, Frank I, Blute ML (2004) Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 28:435–441
de Peralta-Venturina M et al (2001) Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol 25:275–284
Delahunt B (1999) Sarcomatoid renal carcinoma: the final common dedifferentiation pathway of renal epithelial malignancies. Pathology 31:185–190
DeLong W, Grignon DJ, Eberwein P, Shum DT, Wyatt JK (1993) Sarcomatoid renal cell carcinoma. An immunohistochemical study of 18 cases. Arch Pathol Lab Med 117:636–640
Escudier B et al (2002) Doxorubicin and ifosfamide in patients with metastatic sarcomatoid renal cell carcinoma: a phase II study of the Genitourinary Group of the French Federation of Cancer Centers. J Urol 168:959–961. doi:10.1097/01.ju.0000026902.77397.fd
Farrow GM, Harrison EG Jr, Utz DC (1968) Sarcomas and sarcomatoid and mixed malignant tumors of the kidney in adults. II Cancer 22:551–555
Golshayan AR et al (2009) Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy. J Clin Oncol Off J Am Soc Clin Oncol 27:235–241. doi:10.1200/JCO.2008.18.0000
Haas NB et al (2012) A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802. Med Oncol 29:761–767. doi:10.1007/s12032-011-9829-8
Holmang S, Lele SM, Johansson SL (2007) Squamous cell carcinoma of the renal pelvis and ureter: incidence, symptoms, treatment and outcome. J Urol 178:51–56. doi:10.1016/j.juro.2007.03.033
Kassouf W et al (2007) Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology. J Urol 178:1896–1900. doi:10.1016/j.juro.2007.07.037
Lee TY et al (1998) Renal squamous cell carcinoma: CT findings and clinical significance. Abdom Imaging 23:203–208
Mian BM, Bhadkamkar N, Slaton JW, Pisters PW, Daliani D, Swanson DA, Pisters LL (2002) Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol 167:65–70
Molina AM et al (2011) Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease. Am J Clin Oncol 34:454–459. doi:10.1097/COC.0b013e3181f47aa4
Nanus DM, Garino A, Milowsky MI, Larkin M, Dutcher JP (2004) Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma. Cancer 101:1545–1551. doi:10.1002/cncr.20541
Pal SK et al (2013) Clinical outcome in patients receiving systemic therapy for metastatic sarcomatoid renal cell carcinoma: a retrospective analysis. Urol Oncol 31:1826–1831. doi:10.1016/j.urolonc.2012.04.007
Ro JY, Ayala AG, Sella A, Samuels ML, Swanson DA (1987) Sarcomatoid renal cell carcinoma: clinicopathologic. A study of 42 cases. Cancer 59:516–526
Rosenkrantz AB, Chandarana H, Melamed J (2011) MRI findings of sarcomatoid renal cell carcinoma in nine cases. Clin Imaging 35:459–464. doi:10.1016/j.clinimag.2010.11.002
Shuch B et al (2009) Cytoreductive nephrectomy for kidney cancer with sarcomatoid histology—is up-front resection indicated and, if not, is it avoidable? J Urol 182:2164–2171. doi:10.1016/j.juro.2009.07.049
Sivaramakrishna B, Aron M, Ansari MS, Seth A, Goel R, Mundada OP, Balchander (2004) Squamous cell carcinoma of the renal pelvis manifesting after percutaneous nephrolithotomy for long standing calculus. Int Urol Nephrol 36:149–151
Staehler M et al (2010) Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation. Eur J Med Res 15:287–291
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Yi Yan and Longfei Liu have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Yan, Y., Liu, L., Zhou, J. et al. Clinicopathologic characteristics and prognostic factors of sarcomatoid renal cell carcinoma. J Cancer Res Clin Oncol 141, 345–352 (2015). https://doi.org/10.1007/s00432-014-1740-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-014-1740-1